Biotech firm says it now has enough data to seek emergency clearance for coronavirus shots from US regulator agency

Israel Democracy Institue survey shows older people keener than the young, men more willing than women; assesses public may be getting used to living under virus conditions

Mikael Dolsten, the head scientist at Pfizer, eager to point out role of new arrivals to America in crucial scientific breakthroughs

US President-elect makes strongest remarks yet over Trump's refusal to concede election, says refusal will harm national security, efforts to distribute virus vaccine

Massachusetts-based company saw share price soar after announcing its coronavirus vaccine is 94.5% effective. Bullish CEO, promising up to a billion doses, says it's just the start

Kremlin says leaders also discuss producing 'Sputnik V' in Jewish state; phone call comes after Israel strikes deal with Pfizer, in addition to Moderna

Immunizing superspreaders is the 'only way' to protect society with an initially limited supply of inoculations, says Israel Prize-winning physicist Shlomo Havlin

Tal Zaks, who is Israeli, estimates shot will reach Jewish state in early 2021

Chezy Levy reportedly tells ministers Israel will receive maximum of 200,000 shots at year's start, is scolded by PM for unauthorized revelation

Independent monitors from trial say all severe COVID-19 cases were among placebo recipients; Israel, which has made deal with company to purchase shots, welcomes development